Table 1 Baseline characteristics.
From: Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy
Parameter | Central serous chorioretinopathy (36 patients, 36 eyes) |
|---|---|
Age (years) | 50.56 ± 8.55 |
Sex (male/female) | 28 (77.8%)/8 (22.2%) |
Affected eye (right/left) | 20 (55.6%)/16 (44.4%) |
BCVA (LogMAR) | 0.31 ± 0.27 |
Duration (months) | 4.42 ± 2.20 |
Central retinal thickness (µm) | 417.00 ± 147.93 |
Subfoveal choroidal thickness (µm) | 377.75 ± 83.82 |
Presence of PED (yes/no) | 27 (75.0%)/8 (25.0%) |
Dome shaped PED (yes/no) | 8 (29.6%) |
Shallow irregular PED (yes/no) | 20 (74.1%) |
Ellipsoid zone disruption (yes/no) | 23 (63.8%)/13 (36.1%) |
Number of quadrants with macula-draining vortex veins (1/2/3/4 quadrants) | 12 (33.3%)/13 (36.1%)/7 (19.4%)/4 (11.1%) |
